RPSGT study materials
RPSGT study resources

RPSGT cheat sheet

RPSGT · Keep the key ideas within reach.

Quick reference

Patient and Equipment Preparation for Polysomnographic Testing

  • AASM EEG montage: F4-M1, C4-M1, O2-M1 as primary; F3-M2, C3-M2, O1-M2 as backups; EOG E1-M2 and E2-M2; chin EMG with three electrodes.

  • Electrode impedance target is ≤5 kΩ; impedance checks are documented before recording and after any electrode repair.

  • E1 sits 1 cm below and 1 cm lateral to the left outer canthus; E2 sits 1 cm above and 1 cm lateral to the right outer canthus.

  • Chin EMG: one midline electrode 1 cm above the inferior edge of the mandible; two electrodes 2 cm below and 2 cm lateral to midline.

  • Leg EMG: surface electrodes 2-3 cm apart over the anterior tibialis; bilateral recording is recommended for PLM detection.

  • Bio-calibration includes eyes open, eyes closed, left/right gaze, blinks, jaw clench, sniff, leg movements, and breathing.

  • End-tidal CO2 normal range is 35-45 mmHg; transcutaneous CO2 is an alternative for pediatric or ventilation monitoring.

  • A single modified ECG lead on the chest is used to maximize R-wave detection and identify cardiac arrhythmias.

  • Oximetry sampling should provide a stable SpO2 waveform; signal averaging time affects detection of brief desaturations.

Quick reference

Polysomnographic Data Acquisition and Monitoring

  • EEG filter settings: low-frequency 0.3 Hz, high-frequency 35 Hz; EOG 0.3-35 Hz; chin EMG 10-100 Hz.

  • AASM recommends at least 200 Hz sampling for EEG, EOG, EMG, and ECG; airflow and oximetry can be sampled at lower rates.

  • Arousal: abrupt EEG frequency shift ≥3 seconds; in REM, a concurrent chin EMG increase ≥1 second is required.

  • Apnea: ≥90% airflow reduction for ≥10 seconds; obstructive if effort persists, central if effort is absent, mixed if both patterns occur.

  • Hypopnea: ≥30% airflow reduction for ≥10 seconds with ≥3% desaturation or an arousal.

  • PLMS: ≥4 consecutive leg movements, each 0.5-10 seconds, separated by 5-90 seconds.

  • Stage N3: slow waves 0.5-2 Hz and >75 µV occupying ≥20% of the epoch.

  • REM: low-amplitude mixed-frequency EEG, low chin EMG tone, and rapid eye movements; transient muscle activity may persist.

  • MSLT: four or five naps at 2-hour intervals; mean sleep latency ≤8 minutes is abnormal; SOREMP is REM within 15 minutes.

Quick reference

Scoring, Interpretation, and Report Generation

  • Scoring uses 30-second epochs; each epoch receives one stage based on the predominant pattern and transition rules.

  • Sleep onset is the first epoch of any sleep stage after lights out.

  • Stage W: alpha rhythm >50% of the epoch in patients with occipital alpha; without alpha, use eye blinks, reading eye movements, or high chin EMG.

  • N1: low-amplitude mixed-frequency EEG, slow eye movements, and vertex sharp waves; no sleep spindles or K-complexes.

  • N2 begins with a K-complex unassociated with arousal or a sleep spindle in the first half of the epoch or last half of the preceding epoch.

  • N3: ≥20% of the epoch occupied by slow waves of 0.5-2 Hz and >75 µV.

  • REM: low-amplitude mixed-frequency EEG, low chin EMG, and rapid eye movements; chin EMG may show brief twitches.

  • AHI = apneas plus hypopneas per hour of sleep; 5-15 is mild, 15-30 is moderate, and >30 is severe.

  • Report includes study indication, technical quality, sleep architecture, respiratory events, PLM index, ECG findings, and diagnostic impression.

Quick reference

Therapeutic Interventions, Patient Safety, and Professional Standards

  • CPAP titration endpoint: elimination of obstructive apneas, hypopneas, snoring, and desaturations in supine REM sleep.

  • PAP adherence is commonly defined as ≥4 hours per night on ≥70% of nights; Medicare uses a 30-day compliance window.

  • BiPAP is used when high CPAP pressure is poorly tolerated or ventilation is inadequate; ASV targets central sleep apnea and Cheyne-Stokes respiration.

  • Oxygen therapy is added when SpO2 remains <90% despite adequate PAP pressure.

  • Positional therapy is indicated when the AHI is at least twice as high in the supine position as in the nonsupine position.

  • Fall precautions include bed rails, call-light access, assisted ambulation, and alarm response.

  • Infection control: hand hygiene before and after contact and between patients; disinfect reusable electrodes per manufacturer instructions.

  • Professional standards include informed consent, HIPAA confidentiality, accurate documentation, and adherence to the BRPT code of ethics.

  • Emergencies: maintain suction, oxygen, bag-valve-mask, and AED access; activate EMS for chest pain, severe dyspnea, or unresponsiveness.